I’m finding it increasingly fascinating how experimental designs in the lab don’t always translate smoothly into clinical applications. For instance, the recent study on CRISPR effects on sickle cell disease showed promise but faced complications in patient trials. How do you all think we can bridge these gaps more effectively?